Acrylamide monomer

CAS No. 79-06-1

Acrylamide monomer( —— )

Catalog No. M20290 CAS No. 79-06-1

Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acrylamide monomer
  • Note
    Research use only, not for human use.
  • Brief Description
    Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.
  • Description
    Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79-06-1
  • Formula Weight
    71.08
  • Molecular Formula
    C3H5NO
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:14 mg/mL (196.96 mM)
  • SMILES
    NC(=O)C=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chrysophanol 8-O-glu...

    Chrysophanol 8-O-glucoside and chrysophanol have mild cytotoxicity and anti-diabetic properties and can play metabolic roles in the insulin-stimulated glucose transport pathway.

  • Myristoyl glutamic a...

    Myristoyl glutamic acid sodium, a surfactant in amino acid cleansers, has mild antibacterial properties and cleanses the skin surface of excess oil and dirt.

  • ML382

    ML382 is a potent and selective MrgX1 positive allosteric modulator(EC50 : 190 nM).ML382 enhances the ability of BAM8-22 to inhibit high-voltage-activated Ca2+ channels and attenuate spinal nociceptive transmission, both BAM8-22 and ML382 effectively attenuated evoked, persistent, and spontaneous pain without causing obvious side effects.?